R389Q (p.Arg389Gln) variant of TMC1 (Q8TDI8)
R389Q (p.Arg389Gln) in TMC1 (Q8TDI8) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of not provided; Nonsyndromic genetic hearing loss; Autosomal recessive nonsyndromi. The available variant effect predictions contribute to a CATVariant prioritization score of 0.71 / 1. The record also includes population frequency data, published literature, and structural context.
R389Q (p.Arg389Gln) variant details
- p.Arg389Gln
- rs772640673
- ClinGen CA5081885
- cosmic curated COSV99920
- ClinVar RCV003557450
- Pathogenic/Likely pathogenic
- not provided; Nonsyndromic genetic hearing loss; Autosomal recessive nonsyndromi
- Missense
- Variant Prioritization Score for Impact Estimate 0.71
- REVEL 0.59
- ESM-1b 1.00
- AlphaMissense 0.50
- CADD 31.00
- PolyPhen-2 1.00
- SIFT 0.00
- ClinVar: Pathogenic/Likely pathogenic (not provided; Nonsyndromic genetic hearing loss; Autosomal reces)
- EBI: Pathogenic
- UniProt: Pathogenic
- Most common in the Finnish in Finland (FIN) population (allele frequency 0.00019)
- Structural context available
- Cited in: Genetic Hearing Loss Overview. (PMID 20301607)